SIRT2 induces the checkpoint kinase BubR1 to increase lifespan

Brian J. North, Michael A. Rosenberg, Karthik B. Jeganathan, Angela V. Hafner, Shaday Michan, Jing Dai, Darren J Baker, Yana Cen, Lindsay E. Wu, Anthony A. Sauve, Jan Van Deursen, Anthony Rosenzweig, David A. Sinclair

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Mice overexpressing the mitotic checkpoint kinase gene BubR1 live longer, whereas mice hypomorphic for BubR1 (BubR1H/H) live shorter and show signs of accelerated aging. As wild-type mice age, BubR1 levels decline in many tissues, a process that is proposed to underlie normal aging and age-related diseases. Understanding why BubR1 declines with age and how to slow this process is therefore of considerable interest. The sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that can delay age-related diseases. Here, we show that the loss of BubR1 levels with age is due to a decline in NAD+ and the ability of SIRT2 to maintain lysine-668 of BubR1 in a deacetylated state, which is counteracted by the acetyltransferase CBP. Overexpression of SIRT2 or treatment of mice with the NAD+ precursor nicotinamide mononucleotide (NMN) increases BubR1 abundance in vivo. Overexpression of SIRT2 in BubR1H/H animals increases median lifespan, with a greater effect in male mice. Together, these data indicate that further exploration of the potential of SIRT2 and NAD+ to delay diseases of aging in mammals is warranted.

Original languageEnglish (US)
Pages (from-to)1438-1453
Number of pages16
JournalEMBO Journal
Volume33
Issue number13
DOIs
StatePublished - 2014

Fingerprint

NAD
Phosphotransferases
Aging of materials
Nicotinamide Mononucleotide
Sirtuins
Acetyltransferases
Mammals
M Phase Cell Cycle Checkpoints
Lysine
Animals
Genes
Tissue

Keywords

  • acetylation
  • aging
  • BubR1
  • sirtuin

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

North, B. J., Rosenberg, M. A., Jeganathan, K. B., Hafner, A. V., Michan, S., Dai, J., ... Sinclair, D. A. (2014). SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO Journal, 33(13), 1438-1453. https://doi.org/10.15252/embj.201386907

SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. / North, Brian J.; Rosenberg, Michael A.; Jeganathan, Karthik B.; Hafner, Angela V.; Michan, Shaday; Dai, Jing; Baker, Darren J; Cen, Yana; Wu, Lindsay E.; Sauve, Anthony A.; Van Deursen, Jan; Rosenzweig, Anthony; Sinclair, David A.

In: EMBO Journal, Vol. 33, No. 13, 2014, p. 1438-1453.

Research output: Contribution to journalArticle

North, BJ, Rosenberg, MA, Jeganathan, KB, Hafner, AV, Michan, S, Dai, J, Baker, DJ, Cen, Y, Wu, LE, Sauve, AA, Van Deursen, J, Rosenzweig, A & Sinclair, DA 2014, 'SIRT2 induces the checkpoint kinase BubR1 to increase lifespan', EMBO Journal, vol. 33, no. 13, pp. 1438-1453. https://doi.org/10.15252/embj.201386907
North BJ, Rosenberg MA, Jeganathan KB, Hafner AV, Michan S, Dai J et al. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO Journal. 2014;33(13):1438-1453. https://doi.org/10.15252/embj.201386907
North, Brian J. ; Rosenberg, Michael A. ; Jeganathan, Karthik B. ; Hafner, Angela V. ; Michan, Shaday ; Dai, Jing ; Baker, Darren J ; Cen, Yana ; Wu, Lindsay E. ; Sauve, Anthony A. ; Van Deursen, Jan ; Rosenzweig, Anthony ; Sinclair, David A. / SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. In: EMBO Journal. 2014 ; Vol. 33, No. 13. pp. 1438-1453.
@article{2eebd82daac84907a960229a039c2831,
title = "SIRT2 induces the checkpoint kinase BubR1 to increase lifespan",
abstract = "Mice overexpressing the mitotic checkpoint kinase gene BubR1 live longer, whereas mice hypomorphic for BubR1 (BubR1H/H) live shorter and show signs of accelerated aging. As wild-type mice age, BubR1 levels decline in many tissues, a process that is proposed to underlie normal aging and age-related diseases. Understanding why BubR1 declines with age and how to slow this process is therefore of considerable interest. The sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that can delay age-related diseases. Here, we show that the loss of BubR1 levels with age is due to a decline in NAD+ and the ability of SIRT2 to maintain lysine-668 of BubR1 in a deacetylated state, which is counteracted by the acetyltransferase CBP. Overexpression of SIRT2 or treatment of mice with the NAD+ precursor nicotinamide mononucleotide (NMN) increases BubR1 abundance in vivo. Overexpression of SIRT2 in BubR1H/H animals increases median lifespan, with a greater effect in male mice. Together, these data indicate that further exploration of the potential of SIRT2 and NAD+ to delay diseases of aging in mammals is warranted.",
keywords = "acetylation, aging, BubR1, sirtuin",
author = "North, {Brian J.} and Rosenberg, {Michael A.} and Jeganathan, {Karthik B.} and Hafner, {Angela V.} and Shaday Michan and Jing Dai and Baker, {Darren J} and Yana Cen and Wu, {Lindsay E.} and Sauve, {Anthony A.} and {Van Deursen}, Jan and Anthony Rosenzweig and Sinclair, {David A.}",
year = "2014",
doi = "10.15252/embj.201386907",
language = "English (US)",
volume = "33",
pages = "1438--1453",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - SIRT2 induces the checkpoint kinase BubR1 to increase lifespan

AU - North, Brian J.

AU - Rosenberg, Michael A.

AU - Jeganathan, Karthik B.

AU - Hafner, Angela V.

AU - Michan, Shaday

AU - Dai, Jing

AU - Baker, Darren J

AU - Cen, Yana

AU - Wu, Lindsay E.

AU - Sauve, Anthony A.

AU - Van Deursen, Jan

AU - Rosenzweig, Anthony

AU - Sinclair, David A.

PY - 2014

Y1 - 2014

N2 - Mice overexpressing the mitotic checkpoint kinase gene BubR1 live longer, whereas mice hypomorphic for BubR1 (BubR1H/H) live shorter and show signs of accelerated aging. As wild-type mice age, BubR1 levels decline in many tissues, a process that is proposed to underlie normal aging and age-related diseases. Understanding why BubR1 declines with age and how to slow this process is therefore of considerable interest. The sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that can delay age-related diseases. Here, we show that the loss of BubR1 levels with age is due to a decline in NAD+ and the ability of SIRT2 to maintain lysine-668 of BubR1 in a deacetylated state, which is counteracted by the acetyltransferase CBP. Overexpression of SIRT2 or treatment of mice with the NAD+ precursor nicotinamide mononucleotide (NMN) increases BubR1 abundance in vivo. Overexpression of SIRT2 in BubR1H/H animals increases median lifespan, with a greater effect in male mice. Together, these data indicate that further exploration of the potential of SIRT2 and NAD+ to delay diseases of aging in mammals is warranted.

AB - Mice overexpressing the mitotic checkpoint kinase gene BubR1 live longer, whereas mice hypomorphic for BubR1 (BubR1H/H) live shorter and show signs of accelerated aging. As wild-type mice age, BubR1 levels decline in many tissues, a process that is proposed to underlie normal aging and age-related diseases. Understanding why BubR1 declines with age and how to slow this process is therefore of considerable interest. The sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that can delay age-related diseases. Here, we show that the loss of BubR1 levels with age is due to a decline in NAD+ and the ability of SIRT2 to maintain lysine-668 of BubR1 in a deacetylated state, which is counteracted by the acetyltransferase CBP. Overexpression of SIRT2 or treatment of mice with the NAD+ precursor nicotinamide mononucleotide (NMN) increases BubR1 abundance in vivo. Overexpression of SIRT2 in BubR1H/H animals increases median lifespan, with a greater effect in male mice. Together, these data indicate that further exploration of the potential of SIRT2 and NAD+ to delay diseases of aging in mammals is warranted.

KW - acetylation

KW - aging

KW - BubR1

KW - sirtuin

UR - http://www.scopus.com/inward/record.url?scp=84903744004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903744004&partnerID=8YFLogxK

U2 - 10.15252/embj.201386907

DO - 10.15252/embj.201386907

M3 - Article

VL - 33

SP - 1438

EP - 1453

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 13

ER -